Ipilimumab‐induced hypophysitis: early Australian experience
Gespeichert in:
| Veröffentlicht in: | Medical journal of Australia 2014-08, Vol.201 (4), p.198-199 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 199 |
|---|---|
| container_issue | 4 |
| container_start_page | 198 |
| container_title | Medical journal of Australia |
| container_volume | 201 |
| creator | De Sousa, Sunita M C Long, Georgina V Tonks, Katherine T |
| description | |
| doi_str_mv | 10.5694/mja14.00803 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5694_mja14_00803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MJA2198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2978-eaffcc39754c9d892aa5529f3e8ff37d386b81a711621c7d65b3a3488c7eff7e3</originalsourceid><addsrcrecordid>eNp9kMtKw0AYhQdRbK2u3Ev2kjqXTGbGhVCKl0rFjYK7MJn8Q6ckaZhp0Ox8BJ_RJzE26tLV4cDHgfMhdErwlKcquajWmiRTjCVme2hMGE1jzoTYR2OMKY8FVS8jdBTCuq-EU3GIRpSTNJEJHqOrReNKV7WVzj_fP1xdtAaKaNU1m2bVBbd14TIC7csumrVh63XpdB3BWwPeQW3gGB1YXQY4-ckJer65fprfxcvH28V8towNVULGoK01hinBE6MKqajWnFNlGUhrmSiYTHNJtCAkpcSIIuU50yyR0giwVgCboPNh1_hNCB5s1nhXad9lBGffFrKdhWxnoafPBrpp8wqKP_b3dg_gAXh1JXT_bWUP9zNKlGRfCBlo8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ipilimumab‐induced hypophysitis: early Australian experience</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>De Sousa, Sunita M C ; Long, Georgina V ; Tonks, Katherine T</creator><creatorcontrib>De Sousa, Sunita M C ; Long, Georgina V ; Tonks, Katherine T</creatorcontrib><identifier>ISSN: 0025-729X</identifier><identifier>EISSN: 1326-5377</identifier><identifier>DOI: 10.5694/mja14.00803</identifier><identifier>PMID: 25164840</identifier><language>eng</language><publisher>Australia</publisher><subject>Antibodies, Monoclonal - administration & dosage ; Antibodies, Monoclonal - adverse effects ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Australia ; Disease Progression ; Endocrine system diseases ; Glucocorticoids - therapeutic use ; Humans ; Hypopituitarism - chemically induced ; Hypopituitarism - drug therapy ; Hypopituitarism - immunology ; Hypopituitarism - pathology ; Immune system diseases ; Ipilimumab ; Male ; Melanoma - drug therapy ; Melanoma - secondary ; Middle Aged ; Neoplasms ; Prednisolone - therapeutic use ; Skin Neoplasms - drug therapy ; Skin Neoplasms - secondary</subject><ispartof>Medical journal of Australia, 2014-08, Vol.201 (4), p.198-199</ispartof><rights>2014 AMPCo Pty Ltd. All rights reserved</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2978-eaffcc39754c9d892aa5529f3e8ff37d386b81a711621c7d65b3a3488c7eff7e3</citedby><cites>FETCH-LOGICAL-c2978-eaffcc39754c9d892aa5529f3e8ff37d386b81a711621c7d65b3a3488c7eff7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.5694%2Fmja14.00803$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.5694%2Fmja14.00803$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25164840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Sousa, Sunita M C</creatorcontrib><creatorcontrib>Long, Georgina V</creatorcontrib><creatorcontrib>Tonks, Katherine T</creatorcontrib><title>Ipilimumab‐induced hypophysitis: early Australian experience</title><title>Medical journal of Australia</title><addtitle>Med J Aust</addtitle><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Australia</subject><subject>Disease Progression</subject><subject>Endocrine system diseases</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Hypopituitarism - chemically induced</subject><subject>Hypopituitarism - drug therapy</subject><subject>Hypopituitarism - immunology</subject><subject>Hypopituitarism - pathology</subject><subject>Immune system diseases</subject><subject>Ipilimumab</subject><subject>Male</subject><subject>Melanoma - drug therapy</subject><subject>Melanoma - secondary</subject><subject>Middle Aged</subject><subject>Neoplasms</subject><subject>Prednisolone - therapeutic use</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - secondary</subject><issn>0025-729X</issn><issn>1326-5377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKw0AYhQdRbK2u3Ev2kjqXTGbGhVCKl0rFjYK7MJn8Q6ckaZhp0Ox8BJ_RJzE26tLV4cDHgfMhdErwlKcquajWmiRTjCVme2hMGE1jzoTYR2OMKY8FVS8jdBTCuq-EU3GIRpSTNJEJHqOrReNKV7WVzj_fP1xdtAaKaNU1m2bVBbd14TIC7csumrVh63XpdB3BWwPeQW3gGB1YXQY4-ckJer65fprfxcvH28V8towNVULGoK01hinBE6MKqajWnFNlGUhrmSiYTHNJtCAkpcSIIuU50yyR0giwVgCboPNh1_hNCB5s1nhXad9lBGffFrKdhWxnoafPBrpp8wqKP_b3dg_gAXh1JXT_bWUP9zNKlGRfCBlo8w</recordid><startdate>20140818</startdate><enddate>20140818</enddate><creator>De Sousa, Sunita M C</creator><creator>Long, Georgina V</creator><creator>Tonks, Katherine T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140818</creationdate><title>Ipilimumab‐induced hypophysitis: early Australian experience</title><author>De Sousa, Sunita M C ; Long, Georgina V ; Tonks, Katherine T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2978-eaffcc39754c9d892aa5529f3e8ff37d386b81a711621c7d65b3a3488c7eff7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Australia</topic><topic>Disease Progression</topic><topic>Endocrine system diseases</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Hypopituitarism - chemically induced</topic><topic>Hypopituitarism - drug therapy</topic><topic>Hypopituitarism - immunology</topic><topic>Hypopituitarism - pathology</topic><topic>Immune system diseases</topic><topic>Ipilimumab</topic><topic>Male</topic><topic>Melanoma - drug therapy</topic><topic>Melanoma - secondary</topic><topic>Middle Aged</topic><topic>Neoplasms</topic><topic>Prednisolone - therapeutic use</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - secondary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Sousa, Sunita M C</creatorcontrib><creatorcontrib>Long, Georgina V</creatorcontrib><creatorcontrib>Tonks, Katherine T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Medical journal of Australia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Sousa, Sunita M C</au><au>Long, Georgina V</au><au>Tonks, Katherine T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ipilimumab‐induced hypophysitis: early Australian experience</atitle><jtitle>Medical journal of Australia</jtitle><addtitle>Med J Aust</addtitle><date>2014-08-18</date><risdate>2014</risdate><volume>201</volume><issue>4</issue><spage>198</spage><epage>199</epage><pages>198-199</pages><issn>0025-729X</issn><eissn>1326-5377</eissn><cop>Australia</cop><pmid>25164840</pmid><doi>10.5694/mja14.00803</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-729X |
| ispartof | Medical journal of Australia, 2014-08, Vol.201 (4), p.198-199 |
| issn | 0025-729X 1326-5377 |
| language | eng |
| recordid | cdi_crossref_primary_10_5694_mja14_00803 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Australia Disease Progression Endocrine system diseases Glucocorticoids - therapeutic use Humans Hypopituitarism - chemically induced Hypopituitarism - drug therapy Hypopituitarism - immunology Hypopituitarism - pathology Immune system diseases Ipilimumab Male Melanoma - drug therapy Melanoma - secondary Middle Aged Neoplasms Prednisolone - therapeutic use Skin Neoplasms - drug therapy Skin Neoplasms - secondary |
| title | Ipilimumab‐induced hypophysitis: early Australian experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T05%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ipilimumab%E2%80%90induced%20hypophysitis:%20early%20Australian%20experience&rft.jtitle=Medical%20journal%20of%20Australia&rft.au=De%20Sousa,%20Sunita%20M%C2%A0C&rft.date=2014-08-18&rft.volume=201&rft.issue=4&rft.spage=198&rft.epage=199&rft.pages=198-199&rft.issn=0025-729X&rft.eissn=1326-5377&rft_id=info:doi/10.5694/mja14.00803&rft_dat=%3Cwiley_cross%3EMJA2198%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25164840&rfr_iscdi=true |